Goprazol Max

Goprazol Max is an oral medication that contains the proton pump inhibitor omeprazole as its active ingredient; the specific strength and dosage form are not disclosed. Marketed in the European Union, it belongs to the acid‑reducer therapeutic class and works by inhibiting gastric proton pumps to lower stomach acidity.

Goprazol Max is prescribed for conditions that involve excess gastric acid production. It is commonly used in the following clinical situations:

- Management of gastroesophageal reflux disease (GERD) - Treatment of peptic ulcer disease, including duodenal and gastric ulcers - Part of combination therapy for Helicobacter pylori eradication - Prevention of ulcer recurrence in patients at risk - Relief of heartburn and acid indigestion symptoms

Side effects of Goprazol Max vary in frequency and severity. They are typically categorized as follows:

Common: - Headache - Diarrhea or loose stools - Nausea or abdominal discomfort - Flatulence - Constipation - Dry mouth

Serious: - Severe allergic reactions (rash, swelling, difficulty breathing) - Low magnesium levels (hypomagnesemia) with prolonged use - Clostridioides difficile infection presenting as persistent diarrhea - Bone fractures associated with long‑term therapy

Before starting Goprazol Max, consider the following precautions and warnings:

- Assess for known hypersensitivity to omeprazole or other proton pump inhibitors. - Use cautiously in patients with severe liver impairment. - Evaluate the need for long‑term therapy, as extended use may increase fracture risk. - Monitor magnesium levels during prolonged treatment. - Discuss with a healthcare professional if you are pregnant, planning pregnancy, or breastfeeding. - Inform the prescriber of any history of gastric malignancy or Barrett's esophagus.

Goprazol Max can affect the pharmacokinetics of several other medicines. Interactions are grouped as:

Avoid: - Co‑administration with atazanavir or nelfinavir (reduced antiviral efficacy) - Use with clopidogrel (reduced antiplatelet activity)

Use with caution: - Warfarin (potential alteration of INR) - Methotrexate (increased serum levels) - Digoxin (possible increase in concentration) - Certain antifungal agents such as ketoconazole or itraconazole (reduced absorption)